News Related to Ependymoma

Related coverage linked through entity extraction aliases.

Australia launches world-first mRNA vaccine trial for pediatric brain cancer

Feb 24, 2026

Southern RNA and Providence Therapeutics will support a clinical trial testing personalized mRNA cancer vaccines for children with treatment-resistant brain tumors, marking the first multi-site pediatric study of its kind.

TET2 Mutations Enhance Cancer Immunotherapy Response in New Studies

Feb 14, 2026

Research shows TET2-driven clonal hematopoiesis improves immune checkpoint blockade efficacy in solid tumors, while separate studies identify new immune pathways in childhood brain cancers and mechanisms behind immunotherapy resistance.